CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2018. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,730,996 | +5.3% | 143,140 | +32.9% | 0.01% | +20.0% |
| Q1 2024 | $7,342,809 | +8.9% | 107,729 | 0.0% | 0.01% | 0.0% |
| Q4 2023 | $6,743,835 | +32.5% | 107,729 | -4.0% | 0.01% | +25.0% |
| Q3 2023 | $5,091,351 | -14.4% | 112,169 | +5.9% | 0.00% | -20.0% |
| Q2 2023 | $5,948,707 | +24.1% | 105,962 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $4,792,661 | -12.6% | 105,962 | -21.4% | 0.00% | -20.0% |
| Q4 2022 | $5,482,750 | -43.2% | 134,877 | -8.7% | 0.01% | -44.4% |
| Q3 2022 | $9,650,000 | +21.9% | 147,660 | +13.3% | 0.01% | +28.6% |
| Q2 2022 | $7,919,000 | -12.2% | 130,304 | -9.3% | 0.01% | 0.0% |
| Q1 2022 | $9,016,000 | -11.1% | 143,633 | +7.4% | 0.01% | 0.0% |
| Q4 2021 | $10,137,000 | -34.5% | 133,771 | -3.3% | 0.01% | -41.7% |
| Q3 2021 | $15,484,000 | -30.3% | 138,333 | +0.8% | 0.01% | -29.4% |
| Q2 2021 | $22,221,000 | +23.4% | 137,261 | -7.1% | 0.02% | +21.4% |
| Q1 2021 | $18,009,000 | -16.9% | 147,795 | +4.4% | 0.01% | -17.6% |
| Q4 2020 | $21,676,000 | +111.7% | 141,569 | +15.7% | 0.02% | +88.9% |
| Q3 2020 | $10,238,000 | +34.2% | 122,403 | +17.9% | 0.01% | +12.5% |
| Q2 2020 | $7,628,000 | +493.2% | 103,803 | +242.3% | 0.01% | +300.0% |
| Q1 2020 | $1,286,000 | -27.0% | 30,325 | +4.8% | 0.00% | 0.0% |
| Q4 2019 | $1,762,000 | +149.9% | 28,925 | +68.2% | 0.00% | +100.0% |
| Q3 2019 | $705,000 | +7.6% | 17,200 | +23.7% | 0.00% | 0.0% |
| Q2 2019 | $655,000 | -74.0% | 13,900 | -80.3% | 0.00% | -66.7% |
| Q1 2019 | $2,518,000 | +21.5% | 70,500 | -2.8% | 0.00% | 0.0% |
| Q4 2018 | $2,073,000 | +91.8% | 72,557 | +197.6% | 0.00% | +200.0% |
| Q3 2018 | $1,081,000 | +3.3% | 24,383 | +37.0% | 0.00% | 0.0% |
| Q2 2018 | $1,046,000 | – | 17,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |